Amedisys (AMED) Tops Q2 EPS by 18c
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Operating expenses: 347.24M
Today's EPS Names:
UBAB, LOAN, FITB, More
Financial Fact:
Operating expenses: 347.24M
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q2 EPS of $1.54, $0.18 better than the analyst estimate of $1.36. Revenue for the quarter came in at $621.86 million versus the consensus estimate of $612.57 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
- DBV Technologies refreshes ATM program with $150M ADS offering
- Blue Star Gold closes $947,631 non-brokered private placement
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
